« Back
Home /
SKLB 610

SKLB 610

Item no.	TMO-T1895-200mg
Manufacturer	TargetMol
CASRN	1125780-41-7
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9888
Citations	1. Shah A, Mangaonkar A. Ann PharmacOthers. 2015 Jul 16.
Smiles	O(C=1C=C(C(NC)=O)N=CC1)C2=CC=C(NC(=O)C3=CC(C(F)(F)F)=CC=C3)C=C2
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	FGFR inhibitor,PDGFR inhibitor,VEGFR inhibitor
Shipping Condition	Cool pack
Available
Manufacturer - Targets	FGFR\|\|\|VEGFR\|\|\|PDGFR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	415.37
Description	SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, at the concentration of 10 μM in biochemical kinase assays.
Pathways	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T1895-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question